Neuroprotection and other novel therapies for glaucoma

Current Opinion in Pharmacology

Volumn 13, Issue 1, 2013, Pages 1-4

  Nucci, Carlo ^a   Strouthidis, Nicholas G ^b,c   Khaw, Peng Tee ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; AUTOANTIBODY; BIOLOGICAL MARKER;

AGING; AUTOPHAGY; BIOMECHANICS; CELL ENERGY; CELL TRANSPLANTATION; CLINICAL PRACTICE; CONJUNCTIVA DISEASE; DEGENERATIVE DISEASE; FIBROSIS; GENE THERAPY; GLAUCOMA; GLAUCOMA SURGERY; GLIA CELL; IMMUNOCOMPETENT CELL; INTRAOCULAR CELL TRANSPLANTATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MESENCHYMAL STEM CELL; MITOCHONDRION; NANOTECHNOLOGY; NEUROPROTECTION; OCULAR BLOOD FLOW; OCULAR PERFUSION PRESSURE; OPTIC NERVE DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINAL DEGENERATIVE DISEASE; REVIEW; RISK FACTOR; T LYMPHOCYTE; TRABECULAR MESHWORK;

EID: 84871305690     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.10.009     Document Type: Editorial

References (3)

1. H.A. Quigley Glaucoma Lancet 377 2011 1367 1377
2. E.E. Chang, and J.L. Goldberg Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement Ophthalmology 119 2012 979 986
3. T. Krupin, J.M. Liebmann, D.S. Greenfield, R. Ritch, and S. Gardiner Low-Pressure Glaucoma Study Group. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study Am J Ophthalmol 151 2011 671 678